Zimmer Change In Cash from 2010 to 2025

ZBH Stock  USD 104.92  2.43  2.26%   
Zimmer Biomet's Change In Cash is increasing with very volatile movements from year to year. Change In Cash is estimated to finish at about 115.2 M this year. For the period between 2010 and 2025, Zimmer Biomet, Change In Cash quarterly trend regression had median of  75,100,000 and r-value of  0.03. View All Fundamentals
 
Change In Cash  
First Reported
2000-06-30
Previous Quarter
27.1 M
Current Value
148.9 M
Quarterly Volatility
1.1 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 145.1 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 11.09, Dividend Yield of 0.0157 or PTB Ratio of 1.63. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Check out the analysis of Zimmer Biomet Correlation against competitors.

Latest Zimmer Biomet's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
       Timeline  

Zimmer Change In Cash Regression Statistics

Arithmetic Mean(14,894,688)
Coefficient Of Variation(1,827)
Mean Deviation186,278,320
Median75,100,000
Standard Deviation272,173,179
Sample Variance74078.2T
Range1.2B
R-Value0.03
Mean Square Error79316.5T
R-Squared0.0007
Significance0.92
Slope1,478,346
Total Sum of Squares1111173.6T

Zimmer Change In Cash History

2025115.2 M
2024109.7 M
202340.1 M
2022-102.8 M
2021-323.6 M
2020184.2 M
201975.1 M

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's Change In Cash, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Change In Cash109.7 M115.2 M

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Dividend Share
0.96
Earnings Share
4.33
Revenue Per Share
37.807
Quarterly Revenue Growth
0.043
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.